2024 Annual Meeting | C32 - Specialty Population Sleep Disorders

Date Sunday 04/14/24

Time 07:00 AM - 09:00 AM MDT Add To Calendar

Location Colorado Convention Center | 207

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Joyce K. Lee-Iannotti, MD, FAAN

Topic(s) Sleep

Learning Objectives Participants should become familiar with the importance of sleep in special populations, including those most vulnerable to the maleffects of poor sleep. Ppopulations highlighted will include those with traumatic brain injury (mililary and civilian), those in medical and neurology education (namely neurology residents and felllows), and those in high intensity careers, specifically air pilots.

CME Available 2.00 CME credits

Core Competencies Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement

Program Level Intermediate

Program Tracks Brain Health

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator

Teaching Styles Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:05 AM MDT	Speaker	Introduction Joyce K. Lee-Iannotti, MD, FAAN
07:05 AM - 07:45 AM MDT	Speaker	Sleep Medicine in the Traumatic Brain Injury Population J. Kent Werner, Jr., MD, PhD
07:45 AM - 08:15 AM MDT	Speaker	Sleep and Impact on Students and Physician Trainees Joanna S. Fong-Isariyawongse, MD, FAAN
08:15 AM - 08:45 AM MDT	Speaker	Aircraft Pilot Healthcare Avoidance: Screening in a Population We Need to Trust Joshua Luster, MD
08:45 AM - 09:00 AM MDT	Q&A	Questions & Answers Joyce K. Lee-Iannotti, MD, FAAN

Faculty Disclosures
Joyce K. Lee-Iannotti, MD, FAAN	Dr. Lee-Iannotti has nothing to disclose.
J. Kent Werner, Jr., MD, PhD	Dr. Werner has received personal compensation for serving as an employee of Cogentis Therapeutics. Dr. Werner has stock in Cogentis Therapeutics. Dr. Werner has received intellectual property interests from a discovery or technology relating to health care. Dr. Werner has received intellectual property interests from a discovery or technology relating to health care. Dr. Werner has received personal compensation in the range of $100,000-$499,999 for serving as a Neurologist with United States Navy. Dr. Werner has received personal compensation in the range of $50,000-$99,999 for serving as a CEO / CoFounder with Cogentis Therapeutics.
Joanna S. Fong-Isariyawongse, MD, FAAN	Dr. Fong-Isariyawongse has nothing to disclose.
Joshua Luster, MD	Dr. Luster has nothing to disclose.